SteadyMed Files Inter Partes Review to Invalidate United Therapeutics Patent
21 oct. 2015 07h00 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., Oct. 21, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value...
SteadyMed to Participate in Upcoming Investor Conferences
02 sept. 2015 07h30 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value...
SteadyMed to Provide Insights on Recent Corporate Developments and Report Second Quarter 2015 Financial Results
06 août 2015 07h30 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases...
CORRECTING and REPLACING - SteadyMed Reports Recent Developments, Financial Highlights and First Quarter 2015 Financial Results
14 mai 2015 08h53 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., May 14, 2015 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by SteadyMed Ltd. (Nasdaq:STDY), please note that in the first paragraph under the First...
SteadyMed Reports Recent Developments, Financial Highlights and First Quarter 2015 Financial Results
14 mai 2015 07h39 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., May 14, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases...
SteadyMed Granted Additional U.S. Patent With Patent Term Extension
22 avr. 2015 07h00 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., April 22, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY) a specialty pharmaceutical company, today announced the issuance of a new patent from the United States Patent and...
SteadyMed Announces Closing of Initial Public Offering
25 mars 2015 14h26 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the closing of its initial public offering of 4,700,000 ordinary shares at a...
SteadyMed Announces Pricing of Initial Public Offering
20 mars 2015 07h00 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 20, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the pricing of its initial public offering of 4,700,000 ordinary shares at a...
SteadyMed Ltd. Launches Initial Public Offering
09 mars 2015 16h01 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 9, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the launch of its initial public offering of 4,250,000 ordinary shares at an...
SteadyMed Raises $12.2 Million in Equity Financing
29 janv. 2015 08h00 HE
|
SteadyMed Therapeutics
SAN RAMON, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address...